BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 31668381)

  • 1. Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression.
    Kong X; Tu Y; Li B; Zhang L; Feng L; Wang L; Zhang L; Zhou H; Hua X; Ma X
    Mol Metab; 2019 Nov; 29():1-11. PubMed ID: 31668381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLP-1 signaling-regulated SNAP25 is involved in improved insulin secretion in diabetic GK rats after Roux-en-Y gastric bypass surgery.
    Kong X; Lin C; Yang C; Wang X; Li B; Yan D; Yang Y; Hu A; Chen Y; Xu X; Ma X
    Mol Biol Rep; 2024 Jan; 51(1):123. PubMed ID: 38227062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
    Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
    Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FXR-mediated epigenetic regulation of GLP-1R expression contributes to enhanced incretin effect in diabetes after RYGB.
    Kong X; Feng L; Yan D; Li B; Yang Y; Ma X
    J Cell Mol Med; 2024 Mar; 28(6):e16339. PubMed ID: 33611845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice.
    Li K; Zou J; Li S; Guo J; Shi W; Wang B; Han X; Zhang H; Zhang P; Miao Z; Li Y
    Mol Metab; 2020 Jul; 37():100980. PubMed ID: 32305491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FXR controls insulin content by regulating Foxa2-mediated insulin transcription.
    Yan D; Lv M; Kong X; Feng L; Ying Y; Liu W; Wang X; Ma X
    Biochim Biophys Acta Mol Cell Res; 2024 Feb; 1871(2):119655. PubMed ID: 38135007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FXR/Menin-mediated epigenetic regulation of E2F3 expression controls β-cell proliferation and is increased in islets from diabetic GK rats after RYGB.
    Kong X; Yang C; Li B; Yan D; Yang Y; Cao C; Xing B; Ma X
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167136. PubMed ID: 38531483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GK-rats respond to gastric bypass surgery with improved glycemia despite unaffected insulin secretion and beta cell mass.
    Miskelly MG; Shcherbina L; Thorén Fischer AH; Abels M; Lindqvist A; Wierup N
    Peptides; 2021 Feb; 136():170445. PubMed ID: 33197511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roux-en-Y gastric bypass restores islet function and morphology independent of body weight in ZDF rats.
    Mosinski JD; Aminian A; Axelrod CL; Batayyah E; Romero-Talamas H; Daigle C; Mulya A; Scelsi A; Schauer PR; Brethauer SA; Kirwan JP
    Am J Physiol Endocrinol Metab; 2021 Feb; 320(2):E392-E398. PubMed ID: 33427046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FXR Mediates Adenylyl Cyclase 8 Expression in Pancreatic
    Kong X; Li B; Deng Y; Ma X
    J Diabetes Res; 2019; 2019():8915818. PubMed ID: 31485455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of IRS-1 expression in Goto-Kakizaki rats following Roux-en-Y gastric bypass surgery: resolution of type 2 diabetes?
    Li SQ; Zhou Y; Wang Y; Liu Y; Geng DH; Liu JG
    Tohoku J Exp Med; 2011 Nov; 225(3):179-86. PubMed ID: 22001674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roux-en-Y gastric bypass-induced improvement of glucose tolerance and insulin resistance in type 2 diabetic rats are mediated by glucagon-like peptide-1.
    Liu Y; Zhou Y; Wang Y; Geng D; Liu J
    Obes Surg; 2011 Sep; 21(9):1424-31. PubMed ID: 21479766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sitagliptin and Roux-en-Y gastric bypass modulate insulin secretion via regulation of intra-islet PYY.
    Guida C; McCulloch LJ; Godazgar M; Stephen SD; Baker C; Basco D; Dong J; Chen D; Clark A; Ramracheya RD
    Diabetes Obes Metab; 2018 Mar; 20(3):571-581. PubMed ID: 28892258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin downregulates hyperglycemia and reduces pancreatic islet apoptosis after roux-en-y gastric bypass surgery.
    Chai F; Wang Y; Zhou Y; Liu Y; Geng D; Liu J
    Obes Surg; 2011 Jun; 21(6):768-73. PubMed ID: 21240658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Diet on Bile Acid Metabolism and Insulin Resistance in Type 2 Diabetic Rats after Roux-en-Y Gastric Bypass.
    Shan CX; Qiu NC; Liu ME; Zha SL; Song X; Du ZP; Rao WS; Jiang DZ; Zhang W; Qiu M
    Obes Surg; 2018 Oct; 28(10):3044-3053. PubMed ID: 29721762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roux-en-Y gastric bypass promotes expression of PDX-1 and regeneration of beta-cells in Goto-Kakizaki rats.
    Li Z; Zhang HY; Lv LX; Li DF; Dai JX; Sha O; Li WQ; Bai Y; Yuan L
    World J Gastroenterol; 2010 May; 16(18):2244-51. PubMed ID: 20458761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of Roux-en-Y gastric bypass treatment for type 2 diabetes in rats.
    Yu H; Zheng X; Zhang Z
    J Gastrointest Surg; 2013 Jun; 17(6):1073-83. PubMed ID: 23580087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Roux-en-Y gastric bypass surgery on intestinal Akkermansia muciniphila.
    Yan M; Song MM; Bai RX; Cheng S; Yan WM
    World J Gastrointest Surg; 2016 Apr; 8(4):301-7. PubMed ID: 27152136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate enhancement of first-phase insulin secretion and unchanged glucose effectiveness in patients with type 2 diabetes after Roux-en-Y gastric bypass.
    Martinussen C; Bojsen-Møller KN; Dirksen C; Jacobsen SH; Jørgensen NB; Kristiansen VB; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2015 Mar; 308(6):E535-44. PubMed ID: 25628424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A surrogate of Roux-en-Y gastric bypass (the enterogastro anastomosis surgery) regulates multiple beta-cell pathways during resolution of diabetes in ob/ob mice.
    Amouyal C; Castel J; Guay C; Lacombe A; Denom J; Migrenne-Li S; Rouault C; Marquet F; Georgiadou E; Stylianides T; Luquet S; Le Stunff H; Scharfmann R; Clément K; Rutter GA; Taboureau O; Magnan C; Regazzi R; Andreelli F
    EBioMedicine; 2020 Aug; 58():102895. PubMed ID: 32739864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.